MCMelissa J. Carabott

Melissa J. Carabott

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Melissa J. Carabott has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Species-specific loop-mediated isothermal amplification (LAMP) assays for the detection of three blood flukes affecting bluefin tuna aquaculture

    by Melissa J. Carabott, Cecilia Power, Sho Shirakashi, Paul A. Ramsland, Barbara F. Nowak, Nathan J. Bott

    Blood flukes of the genus Cardicola (Digenea: Aporocotylidae) are well-documented health threats to farmed and ranched bluefin tuna (BFT), where infections can result in substantial economic losses. While recombinase polymerase assays (RPA) have been developed for two species of Cardicola , the high degree of sequence conservation across all three species reported from BFT requires an alternative method to enable confident species-level discrimination. The aims of this study were to design, optimise and validate loop-mediated isothermal amplification (LAMP) for the detection of the three Cardicola species which infect BFT, and apply the assays to Pacific bluefin tuna (PBT) cultured in Japan. Species-specific LAMP assays were successfully designed, optimised and validated for C. forsteri , C. opisthorchis and C. orientalis targeting ITS-2 ribosomal DNA. In addition, these assays were applied to DNA from three sample types targeting sites of significant pathology, the heart, gill necropsy and gill biopsy of 15 PBT. Results were compared to outputs of quantitative polymerase chain reactions (qPCR), the gold standard for blood fluke detection in ranched Australian SBT, where LAMP assays were shown to be more sensitive. This research constitutes the first development and application of species-specific LAMP diagnostics for the three described Cardicola species infecting BFT, providing a rapid, cost-effective and accessible alternative to standard molecular diagnostics, informing management and treatment decisions.

  • Open Access

    Rapid point-of-need blood fluke detection in Southern Bluefin Tuna samples using recombinase polymerase amplification coupled with lateral flow test (RPA-LF)

    by Cecilia Power, Melissa J. Carabott, Luke Norbury, Kirsten Rough, Barbara F. Nowak, Nathan J. Bott


  • Open Access

    Preliminary evidence of a life stage specific antibody response to Cardicola spp. (Trematoda: Aporocotylidae) in ranched Southern bluefin tuna, Thunnus maccoyii

    by Maree Widdicombe, Melissa Carabott, Cecilia Power, Emma Wanicek, Daryl L. Evans, Paul A. Ramsland, Barbara F. Nowak, Nathan J. Bott


  • Open Access

    Dynamics of Cardicola spp. Infection in Ranched Southern Bluefin Tuna: First Observation of C. orientalis at Transfer

    by Melissa J. Carabott, Cecilia Power, Maree Widdicombe, Kirsten Rough, Barbara F. Nowak, Nathan J. Bott

    Aporocotylid blood flukes Cardicola forsteri and C. orientalis are an ongoing health concern for the Southern Bluefin Tuna (Thunnus maccoyii, SBT) industry, where infections can lead to morbidity and mortality in ranched SBT populations. This study compared blood fluke infection in SBT from two companies during the 2021 ranching season. Both companies administered the same dosage of praziquantel approximately 5 weeks after transfer, feeding with frozen baitfish daily; the only difference in the company’s practices was that the pontoons were located 2.5 km apart. Infection severity was measured as prevalence and intensity by quantifying adult C. forsteri in SBT heart and copy numbers of C. forsteri and C. orientalis ITS-2 DNA in SBT heart and gills. Data from the 2018 and 2019 harvests of SBT were used to make comparisons with 2021 harvest data. Cardicola orientalis was detected at transfer and no longer detected after treatment with praziquantel. Cardicola spp. were present in 83% of sampled SBT in 2021. Both companies demonstrated similar patterns of infection, and Company A had higher prevalence and intensity of Cardicola spp. infection. Based on C. forsteri ITS-2 DNA, infection intensity at harvest was significantly greater for both companies in 2021 when compared to 2018 and 2019. Continued monitoring of Cardicola spp. in SBT and improvements in diagnostics contribute to our understanding of Cardicola spp. epizootiology and the detection of changes in treatment efficacy.


  • Open Access

    Effects of company and season on blood fluke (Cardicola spp.) infection in ranched Southern Bluefin Tuna: preliminary evidence infection has a negative effect on fish growth

    by Cecilia Power, Melissa Carabott, Maree Widdicombe, Lachlan Coff, Kirsten Rough, Barbara Nowak, Nathan J. Bott

    Aporocotylid blood flukes Cardicola forsteri and C. orientalis are an ongoing health concern for Southern Bluefin Tuna (SBT), Thunnus maccoyii, ranched in Australia. Therapeutic application of praziquantel (PZQ) has reduced SBT mortalities, however PZQ is not a residual treatment therefore reinfection can occur after the single treatment application. This study documents the epidemiology of Cardicola spp. infection in ranched SBT post treatment over three ranching seasons (2018, 2019 and 2021). Infection prevalence (percentage of SBT affected) and intensity (parasite load) was determined by adult fluke counts from heart, egg counts from gill filaments and the use of specific quantitative polymerase chain reaction (qPCR) for detection of C. forsteri and C. orientalis ITS-2 DNA in SBT hearts and gills. SBT Condition Index decreased as intensity of Cardicola spp. DNA in SBT gills increased, suggesting blood fluke infection had a negative effect on SBT growth (Spearman’s r = −0.2426, d.f. = 138, p = 0.0041). Prevalence and intensity of infection indicated PZQ remained highly effective at controlling Cardicola spp. infection in ranched SBT, 10 years after PZQ administration began in this industry. Company A had the highest prevalence and intensity of Cardicola spp. infection in 2018, and Company G had the highest in 2019. No consistent pattern was seen in 2021. Overall, intensity of infection did not increase as ranching duration increased post treatment. Results from this study improve our knowledge of the biology of blood flukes and helps the SBT industry to modify or design new blood fluke management strategies to reduce health risks and improve performance of SBT.